Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAVALIER: Lanthanum vs calcium carbonate for vascular abnormalities in CKD with hyperphosphatemia
jRCTs051180055Completed
- Sponsor
- Grant for pathophysiological research conference in chronic kidney disease
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of lanthanum carbonate in chronic kidney disease (CKD) and hyperphosphatemia (2 arms), sponsored by Grant for pathophysiological research conference in chronic kidney disease. Primary endpoint: Coronary artery calcification score at 1 year. Started Oct 2014; status: completed.
02
Drugs
lanthanum carbonate
03
Conditions
chronic kidney disease (CKD)hyperphosphatemia
Beyond the preview
Go deeper on jRCTs051180055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180055.